Narrative review synthesizes treatment strategies for HPV-induced warts, highlighting digital health implications.
Human papillomavirus (HPV)-induced warts are common dermatological conditions that impose a persistent clinical, psychosocial, and public-health burden despite their benign nature. This review aimed to synthesize current evidence on pharmacological and procedural treatments for HPV-induced warts while examining the growing role of digital health technologies and broader public-health considerations. A structured narrative review with systematic elements was conducted using PubMed, Scopus, and Web of Science, focusing primarily on English-language studies published between 2010 and March 2026. Evidence from clinical trials, systematic reviews, meta-analyses, guidelines, and selected high-quality observational studies was qualitatively synthesized. The findings indicate that conventional therapies, particularly salicylic acid and cryotherapy, remain central to management but are limited by variable efficacy, recurrence, and adherence challenges. Emerging immunotherapeutic approaches and selected procedural modalities, including laser therapy and photodynamic therapy, offer promise for resistant lesions. In parallel, teledermatology, mobile health applications, and artificial intelligence-based image analysis are expanding opportunities for early assessment, follow-up, and patient engagement. The review concludes that optimal management of HPV-induced warts requires a multidisciplinary strategy combining evidence-based treatment, technological innovation, and public-health awareness to improve access, adherence, equity, and patient well-being.
No takes yet. Share an insight, caveat, or question.
Hejna et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: